Advertisement

Primary Liver Cancer in Japan

  • Takayoshi Tobe
  • Haruo Kameda
  • Masahiko Okudaira
  • Masao Ohto
  • Yasuo Endo
  • Michio Mito
  • Eizo Okamoto
  • Kyuichi Tanikawa
  • Masamichi Kojiro

Table of contents

  1. Front Matter
    Pages I-XIV
  2. Epidemiology

    1. Front Matter
      Pages 1-1
    2. Kunio Okuda
      Pages 3-15
  3. Pathology

    1. Front Matter
      Pages 17-17
    2. Masahiko Okudaira
      Pages 19-23
    3. Setsuo Hirohashi, Michiie Sakamoto
      Pages 25-30
    4. Yasuni Nakanuma, Hiroshi Minato, Tetsuji Kida, Tadashi Terada
      Pages 39-50
  4. Etiology

    1. Front Matter
      Pages 51-51
    2. Satoshi Tanaka, Nobu Hattori
      Pages 61-67
    3. Shinako Takada, Katsuyuki Yaginuma, Masayuki Arii, Ikuo Nakamura, Yumiko Shirakata, Midori Kobayashi et al.
      Pages 75-87
  5. Diagnosis

    1. Front Matter
      Pages 89-89
    2. Clinical features and Diagnosis

      1. Yutaka Inagaki, Masashi Unoura, Kenichi Kobayashi
        Pages 93-102
    3. Diagnostic Imaging

      1. Seigo Sakaguchi, Keiji Tohara, Yoshihiko Oka
        Pages 111-128
      2. Osamu Matsui, Yuji Itai
        Pages 129-138
      3. Yuji Itai, Kuni Ohtomo, Osamu Matsui
        Pages 139-151
      4. Kenichi Takayasu, Yukio Muramatsu, Noriyuki Moriyama, Fumihiko Wakao
        Pages 153-160
    4. Tumor markers

  6. Hepatic Function

    1. Front Matter
      Pages 175-175
    2. Evaluation of hepatic function

      1. Fukashi Imai, Kyoichiro Toshima, Mikio Uematsu, Hiromi Kamoshita, Kazuhito Kuga, Haruo Kameda
        Pages 177-183
    3. Hepatic functional reserve and surgical indication

  7. Mass Screening

    1. Front Matter
      Pages 199-199
    2. Kenichiro Hirata, Morimichi Fukuda, Satoaki Mima
      Pages 201-210
  8. Treatment

    1. Front Matter
      Pages 211-211
    2. Surgical treatment

      1. Yoshio Yamaoka, Kaoru Kumada, Takashi Takayasu, Keiichi Ino, Yasuyuki Shimahara, Taisuke Morimoto et al.
        Pages 221-227
      2. Seiji Kawasaki, Masatoshi Makuuchi, Tomoo Kosuge, Tadatoshi Takayama
        Pages 235-242
    3. Conservative and multidisciplinary treatment

      1. Ryusaku Yamada, Kazushi Kishi, Masaki Terada, Tetsuo Sonomura, Morio Sato
        Pages 259-271
      2. Yoshiyuki Shimamura, Masanori Ishii, Masato Ono, Fujio Makita, Ryuzo Sekiguchi, Masahiro Yoshino et al.
        Pages 273-281
      3. Hiroaki Kinoshita, Kazuhiro Hirohashi, Shoji Kubo
        Pages 283-290
      4. Masaaki Ebara, Kazuhiko Kita, Masaharu Yoshikawa, Nobuyuki Sugiura, Masao Ohto
        Pages 291-300
      5. Nobuo Okazaki, Shuichi Okada, Haruhiko Nose, Kazunori Aoki
        Pages 301-305
      6. Yasushi Nagata, Mitsuyuki Abe, Masahiro Hiraoka, Shinitirou Masunaga, Keizo Akuta, Yasumasa Nishimura et al.
        Pages 315-325
      7. Ken Takasaki, Atsushi Aruga
        Pages 335-342
  9. Recurrence

    1. Front Matter
      Pages 343-343
    2. Susumu Yamasaki, Hiroshi Hasegawa, Tadatoshi Takayama, Tomoo Kosuge, Kazuaki Shimada, Junji Yamamoto
      Pages 345-351
    3. Junichi Uchino, Yoshie Une, Yasuaki Nakajima, Naoki Sato, Shinichi Matsuoka, Toshiya Kamiyama et al.
      Pages 353-361
  10. Addendum (1)

    1. Front Matter
      Pages 363-363
    2. Masao Ohto, Fukuo Kondo, Masaaki Ebara
      Pages 365-373
    3. Michio Mito, Hidetaka Ebata, Masayuki Sawa
      Pages 375-383
    4. Masahiko Tomimatsu, Hiroshi Obata
      Pages 393-401
    5. Toshimichi Nakayama, Hideki Saitsu, Kazuharu Shigetomi
      Pages 403-408

About this book

Introduction

Hepatocellular carcinoma (HCC) is common in the Far East and South Africa, but is rare in the United States and Europe. The vast experience of the East, which has led to marked improvement in the prognosis of patients with HCC, is made available to researchers worldwide in this monograph. The book is based on an enormous amount of data that has been collected and analyzed by the Liver Cancer Study Group of Japan. The data stems from a survey on HCC in Japan since 1965 and contains information from more than 30,000 patients with regard to age distribution, past medical history, diagnostic procedures, frequency of HBV-associated antigens and antibodies, surgical and conservative treatments, gross anatomical and histological features of the tumors, pathology of the noncancerous portions, distant metastasis, and survival rate. This data is a tremendous contribution to our understanding of the epidemiology, pathology, and the latest developments of the molecular biology and clinical problems of primary liver cancer.

Keywords

cancer carcinoma liver metastasis molecular biology pathology

Editors and affiliations

  • Takayoshi Tobe
    • 1
  • Haruo Kameda
    • 2
  • Masahiko Okudaira
    • 3
  • Masao Ohto
    • 4
  • Yasuo Endo
    • 5
  • Michio Mito
    • 6
  • Eizo Okamoto
    • 7
  • Kyuichi Tanikawa
    • 8
  • Masamichi Kojiro
    • 9
  1. 1.1st Department of Surgery, Faculty of MedicineKyoto UniversitySakyo-ku, KyotoJapan
  2. 2.The First Department of Internal MedicineJikei University School of MedicineMinato-ku, TokyoJapan
  3. 3.Department of Pathology, School of MedicineKitasato UniversitySagamiharaJapan
  4. 4.First Department of Medicine, School of MedicineChiba UniversityChibaJapan
  5. 5.Sanraku HospitalChiyoda-ku, TokyoJapan
  6. 6.The Second Department of SurgeryAsahikawa Medical CollegeAsahikawa, HokkaidoJapan
  7. 7.The First Department of SurgeryHyogo College of MedicineNishinomiya, HyogoJapan
  8. 8.Second Department of MedicineKurume University School of MedicineKurumeJapan
  9. 9.First Department of PathologyKurume University School of MedicineFukuokaJapan

Bibliographic information